Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HydraMed Night
- Development stage
- Unknown
- Lead developer
- Farmigea
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
HydraMed Night is a preservative-free, lubricating ophthalmic ointment developed by Farmigea for the overnight relief of dry eye symptoms. The formulation combines liquid paraffin, white soft paraffin, and lanolin with vitamin A (retinyl palmitate), chamomile, and calendula extracts. It works by forming a thick, protective, and long-lasting lubricating layer over the ocular surface, supporting the physiological state of the tear film and protecting the cornea from irritation, burning, and redness. It is classified as a medical device in Europe.
- Brand names
- HydraMed Night
- Other names
- HydraMed Night Eye Ointment
Beyond the preview
Go deeper on HydraMed Night.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HydraMed Night.